CDTX vs LLY · rev $1.3M vs P/E 39, rev $65.18B
Cidara Therapeutics Inc (CDTX) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CDTX currently screens at market cap $6.96B. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CDTX and LLY stock pages for the full models.
Not investment advice.